Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland
Prognostic factors and long-term treatment response of interferon β-1a s.c tiw has not been studied in a real-life clinical cohort in Finland. The aim of the paper was to evaluate long-term treatment response, prognostic clinical factors and adherence among interferon β-1a s.c tiw treated patients i...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-11-01
|
| Series: | Neurology International |
| Subjects: | |
| Online Access: | https://www.pagepress.org/journals/index.php/ni/article/view/8177 |